Open Innovation and Intellectual Property Rights are seemingly concepts that are at odds. The idea that there be a flow of ideas into and out of an organisation to the benefit of all parties certainly presents challenges to patent attorneys. The prevailing view of IP as an exclusive right requires modification to support a strategy incorporating open innovation. If used appropriately, IP can actually be an enabler of open innovation, and enhance the returns on such an approach.
This webinar will explore some of the traditional as well as newer constructs for open innovation and present potential structural and execution pitfalls for parties to avoid. The speakers will draw on case-studies to illustrate how to get it right (and wrong), and share some valuable best practices based on their personal experience.
Dr Adrian Bradley
Dr Adrian Bradley (fellow) is a Partner at Cleveland Scott York. His practice is devoted to helping clients achieve their strategic goals by devising and implementing intellectual property strategies to support them.Adrian focuses on healthcare, with specialisms in medical devices and pharmaceuticals. Having trained as a patent attorney in the pharmaceutical industry with Wyeth (now Pfizer), he has a detailed knowledge of product life cycle management in the sector. He works extensively with universities and start-ups in this area. He is a member of the Business Advisory Board of the Institute of Organic Chemistry and Biochemistry (IOCB) in the Czech Republic, a visiting lecturer at the University of Reading, and has delivered many seminars and lectures on technology transfer (and other IP related subjects) in the UK, Europe, Asia and the United States. He is a member of the continuing professional development committee of the Chartered Institute of Patent Attorneys.
Bernard J.Graves Jr.
Bernie Graves is a chemical and material sciences patent attorney, with a particular emphasis on identification and protection of intellectual property rights in the manufacturing sector. Mr. Graves advises clients on the implementation of corporate procedures and policies to protect proprietary technology through all aspects of representation before the United States Patent and Trademark Office, in addition to identification and systematic protection of business and technical trade secret information. Mr. Graves advises corporate clients using tailored methodology for risk-based allocation of scarce financial and human resources to build the intellectual asset base of the enterprise. He provides pragmatic, cost-effective problem solving of day-to-day legal issues for his clients. Additionally, Mr. Graves advises clients in all aspects of intellectual property due diligence, open innovation, and technology transfer, along with patentability and freedom to practice analysis. Prior to joining Baker Donelson, Mr. Graves was vice president and deputy general counsel for a $9B diversified Fortune 500 chemical company, where he served as chief IP counsel for more than 16 years. In this role, he led a group of 15 professionals and support staff in the development of strategy,identification, creation and management of the company's patents, trademarks, and trade secrets.